Novartis Zometa Low, High Doses Have Similar Efficacy - ASCO Study

Novartis' Zometa 4 mg dose showed similar efficacy to the 8 mg dose in a Phase III study comparing zoledronic acid to Novartis' Aredia in the treatment of tumor-induced hypercalcemia, Pierre Major, MD, McMaster University, said May 21 at the American Society of Clinical Oncology annual meeting in New Orleans.

More from Archive

More from Pink Sheet